Search is Powered by Google
Breast Cancer News

2008 American Society Of Breast Disease Pathfinder Lectures

Main Category: Breast Cancer
Also Included In: Women's Health / Gynecology;  Cancer / Oncology
Article Date: 31 Jan 2008 - 16:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

The 2008 American Society of Breast Disease Pathfinder Lectures will be delivered by two giants in the field of breast cancer - Mary-Claire King, PhD, and Bernard Fisher, MD. The Pathfinder Lectures will be part of the Society's Annual Symposium, April 10-12, 2008, at the Hilton San Diego Resort, San Diego, California.

In announcing the recipients of the ASBD's only honorary recognition, Society president Julio A. Ibarra, MD, noted that "through their research and vision this year's honorees -- Mary-Claire King and Bernard Fisher -- have set the highest of standards and benefited the lives of millions of women internationally."

Mary-Claire King is Professor of Medicine and Genetics and an American Cancer Society professor at the University of Washington. She is best known for discovering that BRCA1 mutations can cause hereditary breast cancer. Dr. King's work changed historic views by finding a genetic marker for the existence of BRCA1, which made possible gene location, testing, screening and prophylactic procedures. Dr. King received her doctorate from the University of California, Berkeley, where she taught from 1976 until 1995 before moving to the University of Washington.

Bernard Fisher, MD, is a recognized pioneer in the biology and treatment of breast cancer. He was recently honored by the University of Pittsburgh, where he serves as distinguished service professor of surgery and scientific director of the National Surgical Adjuvant Breast and Bowel Project, which he chaired from 1967 to 1994. Dr. Fisher work has led to an understanding of breast cancer as a systemic disease that metastasizes unpredictably, and that can be treated with a combination of conservative local treatment and systemic therapy.

Established in 2006, the Pathfinder Lectures recognizes the innovators worldwide who have combined research and clinical practice with an interdisciplinary understanding to advance the fight against breast disease and breast cancer. Previous recipients have included Ambassador Nancy Brinker; Patricia Ganz, MD; Jay Harris, MD; Gabriel Hortobagyi, MD; Daniel Kopans, MD; David Page, MD; Melvin Silverstein, MD; Laszlo Tabar, MD; and Umberto Veronesi, MD.

About the American Society of Breast Disease

The American Society of Breast Disease is the leading professional medical society in the United States to serve all physicians and allied professionals committed to and advocating an interdisciplinary team approach to breast cancer and disease management, prevention, early detection, treatment, and research. The Society provides professional education programs and advocates for improvements in breast healthcare.

American Society of Breast Disease





Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
18 Jul 2008
A large study published in The Lancet Oncology has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...